Dr. Reddy's Laboratories Ltd. ADR buy Barclays PLC
Start price
29.01.24
/
50%
€64.00
Target price
29.01.25
€73.92
Performance (%)
16.32%
Price
22.08.24
€74.00
Summary
This prediction is currently active. The prediction currently has a performance of 16.32%. A total of €0.44 was paid as dividends for this prediction. This prediction currently runs until 29.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 0.680% | 0.680% |
| iShares Core DAX® | 1.665% | 0.362% |
| iShares Nasdaq 100 | -0.475% | -3.195% |
| iShares Nikkei 225® | 2.620% | 1.174% |
| iShares S&P 500 | -0.091% | -1.597% |
Comments by Barclays_PLC for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target raised by analysts at Barclays PLC from $75.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for RDY provided by MarketBeat
Stopped prediction by Barclays_PLC for Dr. Reddy's Laboratories Ltd. ADR
Dr. Reddy's Laboratories Ltd. ADR
Start price
Target price
Perf. (%)
€74.50
30.07.24
30.07.24
€80.52
30.07.25
30.07.25
-0.67%
22.08.24
22.08.24
Dr. Reddy's Laboratories Ltd. ADR
Start price
Target price
Perf. (%)
€65.00
08.05.24
08.05.24
€75.37
08.05.25
08.05.25
14.53%
22.08.24
22.08.24